Cargando…
Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT‐P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects
AIMS: To evaluate pharmacokinetic equivalence and preliminary safety of the adalimumab biosimilar CT‐P17 administered via autoinjector (CT‐P17 AI) or prefilled syringe (CT‐P17 PFS) in healthy subjects. METHODS: This phase I, open‐label study (ClinicalTrials.gov: NCT04295356) randomised subjects (1:1...
Autores principales: | Davidson, Antonia, Brimhall, Darin, Kay, Jonathan, Keystone, Edward, Lee, Sang Joon, Kim, Sung Hyun, Bae, Yun Ju, Choi, Eun Jin, Furst, Daniel E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597139/ https://www.ncbi.nlm.nih.gov/pubmed/33822406 http://dx.doi.org/10.1111/bcp.14850 |
Ejemplares similares
-
Comparative pharmacokinetics of an adalimumab biosimilar SB5 administered via autoinjector or prefilled syringe in healthy subjects
por: Shin, Donghoon, et al.
Publicado: (2018) -
Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe
por: Cohen, Yehuda Z., et al.
Publicado: (2022) -
Pharmacokinetic and Pharmacodynamic Bioequivalence of Pegfilgrastim-cbqv Delivered via a Prefilled Autoinjector and Prefilled Syringe in Healthy Male Participants
por: Tang, Hong, et al.
Publicado: (2023) -
GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes
por: von Richter, Oliver, et al.
Publicado: (2016) -
Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies
por: Stauffer, Virginia L, et al.
Publicado: (2018)